Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) announced in Q2 CY2026, with sales up 2.8% year on year to $630.9 million. On the other hand, the company’s full-year revenue guidance of $2.56 ...

Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) missed Wall Street’s revenue expectations in Q3 2026, with revenue ...

SAN DIEGO (AP) — SAN DIEGO (AP) — QuidelOrtho Corporation (QDEL) on Tuesday reported a loss of $53.8 million in its third ...

PRNewswire/ -- (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a leading global provider of diagnostic solutions, today ...

A number of stocks fell in the afternoon session after capital-intensive growth equities experienced sharp sell-offs as elevated bond yields restricted market appetite for risk.

Earnings: -$53.8 million in Q3 vs. -$733.0 million in the same period last year. EPS: -$0.78 in Q3 vs. -$10.78 in the same period last year. Excluding items, QuidelOrtho Corporation reported adjusted ...

The LEX VELO System is a breakthrough molecular diagnostics platform that is designed to deliver highly sensitive, multiplex RT-PCR testing for Influenza A, Influenza B and COVID-19 directly from a ...

QuidelOrtho (QDEL) stock jumps 11% on heavy volume. Review key levels, RSI, short interest, and debt/covenant risks—read the ...

QuidelOrtho stock (ISIN US2197981051) gained 12.72 percent to USD 12.14 on Nasdaq on October 5, 2026, at 4:00 p.m. ET. The move put the diagnostic-testing company 65.9 percent below its 52-week high ...

QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of diagnostic solutions, announced today that it will issue a press release to report its financial results for the ...

Shares of QuidelOrtho Corporation , a global in-vitro diagnostics company, climbed nearly 13% on Monday, closing at $12.14 after advancing $1.